This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Arthrex Inc., a global leader in minimally invasive orthopedic products and procedures. The $7,700.88 fixed-price delivery order is for the supply of ARTHROCELL PLUS ALLOGRAFT, a 5.0cc biological product used in orthopedic procedures. The contract has an ultimate completion date of December 23, 2024.
Arthrex Inc. is a for-profit Subchapter S Corporation headquartered in Naples, Florida. The company specializes in developing and manufacturing innovative orthopedic technologies, surgical implants, instruments, and biologics. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $471,048,172.66, which allows VA medical centers nationwide to acquire Arthrex's orthopedic products through task orders. The contract does not have a set-aside designation, indicating Arthrex's strong competitive position in the federal market.
Generated 3/19/25, 9:51 AM